Skip to main content

Plaintiff's Motion To Rule Out Certain Evidence Denied

Plaintiff's Motion To Rule Out Certain Evidence Denied

Plaintiff's Motion To Rule Out Certain Evidence Denied

Introduction

In an order issued on September 4, Senior Judge David Campbell, overlooking C.R. Bard IVC Filter litigation, denied a motion filed by a plaintiff to exclude evidence linked to the device instructions from the next bellwether trial.

The motion filed by the plaintiff stated certain guidelines published by the Society of Interventional Radiologists (SIR) be barred from use in the upcoming trial.  However, the Arizona federal judge denied the request on the fact that the instructions are relevant to the design defect claims filed by the plaintiff. The plaintiff was implanted with a Bard IVC filter in 2011 to treat her deep-vein thrombosis and pulmonary embolisms. While Bard stated an Eclipse model was implanted, the plaintiff indicates it was G2X Blood vessel filter.  In 2014, the device was found to be fractured and was eventually removed.

C.R. Bard's G2 Series of IVC Filter has been reported to rupture easily and migrate into the body, perforating blood vessels and other organs. Bard faces more than 3,800 lawsuits related to the severe internal injuries caused due to the device breakage. Multidistrict litigation (MDL No.2641; In Re: Bard IVC Filters Products Liability Litigation) was created on August 17, 2015, in the United States District Court District of Arizona, presided over by Judge David G. Campbell for centralized pretrial proceedings.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.